Status:
UNKNOWN
Immunotherapy in Lung Cancer: Treatment After IO Cessation.
Lead Sponsor:
European Lung Cancer Working Party
Conditions:
Carcinoma, Non-Small-Cell Lung
Immunotherapy
Eligibility:
All Genders
18+ years
Brief Summary
Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determin...
Detailed Description
Patients with stage IV or unresectable not irradiable stage III NSCLC will be registered at the time receiving immunotherapy alone or in combination with chemotherapy. When IO is stopped, reason for ...
Eligibility Criteria
Inclusion
- Histological diagnosis of non-small cell lung cancer (NSCLC)
- Stage IVA/IVB and unresectable and non irradiable stage III NSCLC naïve of immunotherapy.
- Patients who receive immunotherapy (any type) monotherapy, combined immunotherapy or in combination with chemotherapy for first or second-line treatment.
- Availability for participating in the detailed follow-up of the protocol.
- Signed informed consent.
Exclusion
- Patients receiving adjuvant immunotherapy for stage I-III NSCLC are not eligible
- Tumours for which TNM stage at time of study inclusion cannot be assessed.
- History of prior malignant tumour, except non-melanoma skin cancer or in situ carcinoma of the cervix or of the bladder or cured malignant tumor (more than 5-year disease free interval).
- Any type of immunotherapy for previous cancer
Key Trial Info
Start Date :
June 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04465942
Start Date
June 26 2020
End Date
June 1 2025
Last Update
August 23 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet
Brussels, Belgium, 1000
2
Department of Pneumology CHU Charleroi
Charleroi, Belgium, 6000
3
Department of Pneumology Hôpital Saint-Joseph
Gilly, Belgium, 6060
4
Hôpital Ambroise Paré
Mons, Belgium, 7000